NHS England to fund Duodopa

News

Author: Parkinson's Life editorsPublished: 28 August 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The NHS in England has announced they will fund Duodopa – a life-changing drug for people with advanced Parkinson’s – after campaigners managed to garner the support of nearly a hundred MPs who signed a petition.

This means that should a specialist Parkinson’s clinician prescribe Duodopa, a patient will be able to receive it without delay. Duodopa can help to control the symptoms of advanced Parkinson’s when all other treatments have stopped working.

The petition signed by 98 MPs put pressure on NHS England to act urgently to address the situation.

Laura Cockram, policy and campaigns manager at Parkinson’s UK said: “I am elated that the NHS has finally arrived at this decision. We know this treatment has had transformative effects on many that have been treated with it and how vital it is that those who need Duodopa receive it without delay. This is an important day for Parkinson’s care.”

 

Go Back

Share this story

Comments


Related articles


Physiotherapist Josefa Domingos leads an exercise class

Europe

Awareness-raising Parkinson’s initiatives awarded €3,000 grants

Find out what the awardees hope they achieve

READ MORE
Nudgu lead

Carers' Corner

Now there’s an app to remind your loved ones to take their Parkinson’s meds

Introducing the voice reminder service for Parkinson’s carers

READ MORE

Resources & Tools

8 smart Parkinson’s apps you need to try

Smartphone apps that can help track and manage Parkinson's

READ MORE